PubMed

Exploring the equity of GP practice prescribing rates for selected coronary heart disease drugs: a multiple regression analysis with proxies of healthcare need.

Ward PR, Noyce PR, St Leger AS.

Int J Equity Health. 2005 Feb 8;4(1):3.PMID: 15701165 [PubMed - as supplied by publisher]Free PMC ArticleFree textRelated citations

How equitable are GP practice prescribing rates for statins?: an ecological study in four primary care trusts in North West England.

Ward PR, Noyce PR, St Leger AS.

Int J Equity Health. 2007 Mar 27;6:2.PMID: 17386118 [PubMed]Free PMC ArticleFree textRelated citations

Are GP practice prescribing rates for coronary heart disease drugs equitable? A cross sectional analysis in four primary care trusts in England.

Ward PR, Noyce PR, St Leger AS.

J Epidemiol Community Health. 2004 Feb;58(2):89-96.PMID: 14729882 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Differential associations between actual and expected GP practice prescribing rates for statins, ACE inhibitors, and beta-blockers: a cross-sectional study in England.

Ward PR, Noyce PR, St Leger AS.

Ther Clin Risk Manag. 2005 Mar;1(1):61-8.PMID: 18360545 [PubMed - in process]Free PMC ArticleFree textRelated citations

Explaining variation in antidepressant prescribing rates in east London: a cross sectional study.

Hull SA, Aquino P, Cotter S.

Fam Pract. 2005 Feb;22(1):37-42. Epub 2005 Jan 7.PMID: 15640295 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Developing prevalence-based prescribing units for analysing variations in general practitioner prescribing: a case study using statins.

Ward PR, Noyce PR, St Leger AS.

J Clin Pharm Ther. 2003 Feb;28(1):23-9.PMID: 12605615 [PubMed - indexed for MEDLINE]Related citations

Statin prescribing in Nottingham general practices: a cross-sectional study.

Packham C, Robinson J, Morris J, Richards C, Marks P, Gray D.

J Public Health Med. 1999 Mar;21(1):60-4. Erratum in: J Public Health Med 2000 Jun;22(2):250. PMID: 10321861 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner 'Quality and Outcomes Framework'.

Ashworth M, Lloyd D, Smith RS, Wagner A, Rowlands G.

J Public Health (Oxf). 2007 Mar;29(1):40-7. Epub 2006 Oct 27.PMID: 17071815 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Practice characteristics and prescribing of cardiovascular drugs in areas with higher risk of CHD in Scotland: cross-sectional study.

McLean G.

Int J Equity Health. 2008 Jul 15;7:18.PMID: 18627614 [PubMed - in process]Free PMC ArticleFree textRelated citations

Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.

Lee HY, Cooke CE, Robertson TA.

J Manag Care Pharm. 2008 Apr;14(3):271-80.PMID: 18439049 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Prescribing rates for psychotropic medication amongst east London general practices: low rates where Asian populations are greatest.

Hull SA, Cornwell J, Harvey C, Eldridge S, Bare PO.

Fam Pract. 2001 Apr;18(2):167-73.PMID: 11264267 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Explanations for variations in clopidogrel prescribing in England.

Petty DR, Silcock J.

J Public Health (Oxf). 2008 Dec;30(4):494-8. Epub 2008 Jun 30.PMID: 18591212 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

The causes and effects of socio-demographic exclusions from clinical trials.

Bartlett C, Doyal L, Ebrahim S, Davey P, Bachmann M, Egger M, Dieppe P.

Health Technol Assess. 2005 Oct;9(38):iii-iv, ix-x, 1-152. Review.PMID: 16181564 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?

Wachtel TM, Kucia AM, Greenhill JA.

Rural Remote Health. 2008 Oct-Dec;8(4):967. Epub 2008 Oct 14.PMID: 18855517 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

A systematic review and economic evaluation of statins for the prevention of coronary events.

Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.

Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.PMID: 17408535 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Influence of practices' ethnicity and deprivation on access to angiography: an ecological study.

Jones M, Ramsay J, Feder G, Crook AM, Hemingway H.

Br J Gen Pract. 2004 Jun;54(503):423-8.PMID: 15186562 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Changes in prevalence of and prescribing for ischaemic heart disease in Ireland 1990-2002.

Bennett K, Johnson H, Dack P, Shelley E, Feely J.

Ir J Med Sci. 2005 Jul-Sep;174(3):4-8.PMID: 16285330 [PubMed - indexed for MEDLINE]Related citations

Five-year follow-up of drug utilization for secondary prevention in coronary artery disease.

Apikoglu Rabus S, Izzettin FV, Sancar M, Karakaya O, Kargin R, Yakut C.

Pharm World Sci. 2008 Dec;30(6):753-8. Epub 2008 Jun 19.PMID: 18563622 [PubMed - indexed for MEDLINE]Related citations

Trends and inequities in beta-blocker prescribing for heart failure.

Shah SM, Carey IM, DeWilde S, Richards N, Cook DG.

Br J Gen Pract. 2008 Dec;58(557):862-9.PMID: 19068160 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.

Fidan D, Unal B, Critchley J, Capewell S.

QJM. 2007 May;100(5):277-89. Epub 2007 Apr 21.PMID: 17449875 [PubMed - indexed for MEDLINE]Free ArticleRelated citations